Features
Jassy Promotion Dims Amazon Web Services Spinoff
The promotion likely will reduce the chance of Amazon spinning off AWS into its own business in the coming years.
Features
Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.
Click Here
Features
Rise Of Catholic Investing Boosts ESG Trend
Catholic investing joins Islamic finance, ESG metrics, and green bonds as a way of making money ethically.
Capital Raising & Corporate Finance
Bitcoin Comes Of Age
Once shunned by Wall Street, Bitcoin is going mainstream.
Capital Raising & Corporate Finance
European Banks’ Merry-Go-Round
Executives at banks across Europe are trading top posts with one another.
Capital Raising & Corporate Finance
Food Finance
The new frontiers in banking include mobile payments, blockchain, inclusion and … agriculture?
Capital Raising & Corporate Finance
Hitachi Goes Global With Sale
The deal is part of Hitachi’s ongoing strategy to de-emphasize lines of business outside its core focus of information technology.
Features
Honoring A Colleague
Global Finance names its foreign exchange awards in honor of Gordon W. Platt Jr., a beloved and devoted editor, friend and global citizen.
Capital Raising & Corporate Finance
New Tech Listings Roll On
The world economy may be down but IPOs are up.
Capital Raising & Corporate Finance
NTT Bond Sale Sets A Record
Japan’s Nippon Telegraph & Telephone Corp. will use the proceeds to pay for the acquisition of its mobile unit.
Capital Raising & Corporate Finance
Rebound For Pharma M&A
The pharmaceutical sector is consolidating.
Capital Raising & Corporate Finance
Rising Consciousness: The Rise Of Social Bonds
Investor demand, bolstered by Covid-19 concerns, have kicked off a global surge in social bond issuance.
Features
Funding A Solution: aMoon Managing Director Dr. Gur Roshwalb Q&A
Dr. Gur Roshwalb, a former medical practitioner and now managing director at aMoon, a health technology and life sciences venture fund, discusses how Covid-19 is changing biotech investing, what he looks for as an investor and which new sectors are gaining momentum.